BioAcyl Corp |
![]() |
| Resource type: Journal Article DOI: https://doi.org/10.1016/j.smim.2009.01.005 ID no. (ISBN etc.): 1044-5323 BibTeX citation key: Wissinger2009 View all bibliographic details |
Categories: BioAcyl Corp Subcategories: Microenvironment Creators: Goulding, Hussell, Wissinger Collection: Seminars in Immunology |
Views: 1/65
|
| Abstract |
|
Innate immunity at mucosal surfaces requires additional restraint to prevent inflammation to innocuous antigens or commensal microorganisms. The threshold above which airway macrophages become activated is raised by site-specific factors including the receptors for transforming growth factor beta, interleukin 10 and CD200; the ligands for which are produced by, or expressed on, respiratory epithelium. We discuss such site-specific regulation and how this is continually altered by prior infections. Resetting of innate reactivity represents a strategy for limiting excessive inflammation, but in some may pre-dispose to secondary bacterial pneumonia.
|
| Notes |
|
Barrier Immunity
|